
Pfizer Inc. (PFE) discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas.
On August 8, 2022, PFE declared that it would acquire the renowned biopharmaceutical company, Global Blood Therapeutics, Inc. (GBT), under a special agreement, for co-developing advanced treatment and support programs concerning Sickle Cell Disease. This is expected to diversify PFE’s portfolio.